Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...
could provide an effective alternative to combined corticosteroids and cytotoxic agents in the treatment of ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED SMALL VESSEL VASCULITIS (ANCA-SVV).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback